Toronto Dominion Bank increased its stake in shares of Envision Healthcare Corporation (NYSE:EVHC) by 14.8% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,694 shares of the company’s stock after acquiring an additional 5,904 shares during the period. Toronto Dominion Bank’s holdings in Envision Healthcare Corporation were worth $2,054,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. Janus Henderson Group PLC increased its stake in Envision Healthcare Corporation by 36,086.8% in the 2nd quarter. Janus Henderson Group PLC now owns 3,945,087 shares of the company’s stock valued at $247,239,000 after buying an additional 3,934,185 shares during the last quarter. Maverick Capital Ltd. increased its stake in Envision Healthcare Corporation by 66.2% in the 2nd quarter. Maverick Capital Ltd. now owns 5,093,292 shares of the company’s stock valued at $319,197,000 after buying an additional 2,028,026 shares during the last quarter. Lord Abbett & CO. LLC increased its stake in Envision Healthcare Corporation by 259.6% in the 2nd quarter. Lord Abbett & CO. LLC now owns 1,321,328 shares of the company’s stock valued at $82,808,000 after buying an additional 953,928 shares during the last quarter. Westfield Capital Management Co. LP acquired a new stake in Envision Healthcare Corporation in the 2nd quarter valued at $45,892,000. Finally, American Century Companies Inc. acquired a new stake in Envision Healthcare Corporation in the 2nd quarter valued at $31,861,000.

WARNING: This report was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/11/23/envision-healthcare-corporation-evhc-shares-bought-by-toronto-dominion-bank.html.

Shares of Envision Healthcare Corporation (EVHC) opened at $30.06 on Thursday. The company has a market cap of $3,626.68, a PE ratio of 9.26, a P/E/G ratio of 0.78 and a beta of 0.69. The company has a debt-to-equity ratio of 0.89, a quick ratio of 3.00 and a current ratio of 3.01. Envision Healthcare Corporation has a twelve month low of $23.77 and a twelve month high of $74.75.

Envision Healthcare Corporation (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.08). The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. Envision Healthcare Corporation had a positive return on equity of 4.88% and a negative net margin of 6.39%. The business’s quarterly revenue was up 142.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.13 EPS. analysts forecast that Envision Healthcare Corporation will post 2.57 earnings per share for the current fiscal year.

Envision Healthcare Corporation announced that its Board of Directors has approved a stock repurchase program on Monday, September 18th that authorizes the company to buyback $250.00 million in shares. This buyback authorization authorizes the company to reacquire up to 4.5% of its shares through open market purchases. Shares buyback programs are generally a sign that the company’s board believes its stock is undervalued.

Several equities research analysts have issued reports on the stock. Mizuho lowered their price target on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 9th. Citigroup Inc. lowered shares of Envision Healthcare Corporation from a “buy” rating to a “neutral” rating and set a $31.00 price target on the stock. in a research note on Thursday, November 2nd. BidaskClub lowered shares of Envision Healthcare Corporation from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 17th. Bank of America Corporation lowered their price objective on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. Finally, Canaccord Genuity restated a “buy” rating and set a $32.00 price objective (down from $68.00) on shares of Envision Healthcare Corporation in a research note on Thursday, November 2nd. One analyst has rated the stock with a sell rating, six have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. Envision Healthcare Corporation presently has an average rating of “Buy” and a consensus price target of $47.57.

Envision Healthcare Corporation Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Corporation (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.